Showing Results for
- Academic Journals (22)
Search Results
- 22
Academic Journals
- 22
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedThe tumor suppressor TP53 is the most frequently mutated gene in human cancers. Mutant p53 (mutp53) proteins often accumulate to very high levels in human cancers to promote cancer progression through the...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedMutations in the human progranulin (GRN) gene are a leading cause of frontotemporal lobar degeneration (FTLD). While previous studies implicate aberrant microglial activation as a disease-driving factor in...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedTick bites have been shown to transmit a novel form of severe food allergy, the galactose-[alpha]-1,3-galactose ([alpha]-Gal) syndrome (AGS). Cellular responses to [alpha]-Gal in patients with AGS have, to date, not been...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedConnexins are crucial cardiac proteins that form hemichannels and gap junctions. Gap junctions are responsible for the propagation of electrical and chemical signals between myocardial cells and cells of the specialized...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedStimulator of IFN genes type I (STING-Type I) IFN signaling in myeloid cells plays a critical role in effective antitumor immune responses, but STING agonists as monotherapy have shown limited efficacy in clinical...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedJong-Seok Moon, Seonmin Lee, Mi-Ae Park, Ilias I. Siempos, Maria Haslip, Patty J. Lee, Mijin Yun, Chun K. Kim, Judie Howrylak, Stefan W. Ryter, Kiichi Nakahira, and Augustine M.K. Choi Original citation: J Clin Invest....
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedPathogens and inflammatory conditions rapidly induce the expression of immune-responsive gene 1 (IRG1) in cells of myeloid lineage. IRG1 encodes an aconitate decarboxylase (ACOD1) that produces the immunomodulatory...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedCOVID-19 in immunocompromised hosts has emerged as a difficult therapeutic management problem. Immunocompromised hosts mount weak responses to SARS-CoV-2 and manifest infection outcomes ranging from severe disease to...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedTo the Editor: Extremes in birth weight are associated with adverse pregnancy outcomes and long-term risk of cardiometabolic disease. Fetal insulin has long been recognized as an important regulator of fetal growth, but...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedUncontrolled inflammation occurred in sepsis results in multiple organ injuries and shock, which contributes to the death of patients with sepsis. However, the regulatory mechanisms that restrict excessive inflammation...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedMyeloproliferative neoplasms (MPNs) are characterized by the activated JAK2/STAT pathway. Pleckstrin-2 (Plek2) is a downstream target of the JAK2/STAT5 pathway and is overexpressed in patients with MPNs. We previously...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedMycobacterium tuberculosis, the causative agent of tuberculosis (TB), infects primarily macrophages, causing them to differentiate into lipid-laden foamy macrophages that are a primary source of tissue destruction in...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedBACKGROUND. The role of host immunity in emergence of evasive SARS-CoV-2 Spike mutations under therapeutic monoclonal antibody (mAb) pressure remains to be explored. METHODS. In a prospective, observational,...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedBACKGROUND. Antiretroviral therapy (ART) halts HIV-1 replication, decreasing viremia to below the detection limit of clinical assays. However, some individuals experience persistent nonsuppressible viremia (NSV)...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedBACKGROUND. Relatlimab plus nivolumab (anti-lymphocyte-activation gene 3 plus anti-programmed death 1 [anti- [LAG3.sup.+]anti-PD-1]) has been approved by the FDA as a first-line therapy for stage III/IV melanoma, but its...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedHigh mobility group A1 (HMGA1) chromatin regulators are upregulated in diverse tumors where they portend adverse outcomes, although how they function in cancer remains unclear. Pancreatic ductal adenocarcinomas (PDACs)...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedHIV-1 replication can be suppressed with antiretroviral therapy (ART), but individuals who stop taking ART soon become viremic again. Some people experience extended times of detectable viremia despite optimal adherence...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedTreatment options for alcohol use disorders (AUDs) have minimally advanced since 2004, while the annual deaths and economic toll have increased alarmingly. Phosphodiesterase type 4 (PDE4) is associated with alcohol and...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedA subset of the neurodegenerative disease frontotemporal lobar degeneration (FTLD) is caused by mutations in the progranulin (GRN) gene. In this issue of the JCI, Marsan and colleagues demonstrate disease-specific...
-
From:Journal of Clinical Investigation (Vol. 133, Issue 6) Peer-ReviewedInduction of lipid-laden foamy macrophages is a cellular hallmark of tuberculosis (TB) disease, which involves the transformation of infected phagolysosomes from a site of killing into a nutrient-rich replicative niche....